Suzuken Co., Ltd.
SZUKF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.34B
Close$
$10.89
37.3% downside
Current Fair Value
37.3% downsideOvervalued by 37.3% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $2.34 Billion |
|---|---|
| Enterprise Value | $-94,700,927,360.00 |
| Annual dividend | $0.65 |
| Dividend yield | 3.81% |
| Earnings per Share | $274.82 |
| Beta | 0.23 |
| Outstanding Shares | 134,624,000 |
Return
| Return on Equity | 9.08% |
|---|---|
| Return on Assets | 3.16% |
| Return on Invested Capital | 11.81% |
Valuation & Multiples
| P/E Ratio | 10.63 |
|---|---|
| PEG | -100.29 |
| Price to Sales | 0.0 |
| Price to Book Ratio | 0.01 |
| Enterprise Value to Revenue | 0.12 |
| Enterprise Value to EBIT | 5.62 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 0.08 |
| Debt to Equity | 0.06 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 7, 2026
EPS Estimate
$0.22
Consensus analyst estimateRevenue Estimate
$3.76 B
Consensus analyst estimateNext Earnings Call
Expected Date
November 12, 2026
EPS Estimate
$0.33
Consensus analyst estimateRevenue Estimate
$4.14 B
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Suzuken Co., Ltd.
12,717 employees
CEO: Shigeru Asano
Suzuken Co., Ltd., along with its affiliated companies, operates primarily as a wholesale distributor of pharmaceuticals, serving both domestic and international markets. The company's diverse activities are organized into four distinct ...